Board of Directors

medium_Pamela Fralick

Pamela Fralick

Director - SignPost Cancer Dx Inc.

Ms. Fralick is the former President and CEO of the Canadian Cancer Society.

Ms. Fralick led a three-year process of intense transformation, resulting in significant improvements to the operational and governance structures of the organization. Prior to this, she spent five years as president and CEO of the Canadian Healthcare Association, a federation of provincial and territorial hospital and health organizations, as well as six years as CEO of the Canadian Physiotherapy Association. She was chair of the Health Action Lobby (HEAL) and co-chair of the Canadian Coalition for Public Health in the 21st Century (CCPH21).

Read more...

nicol-macnicol

Nicol MacNicol

Chairman – SignPost Cancer Dx. Inc.

Nicol is a Portfolio Manager at Caldwell Securities specializing in working with Individuals, Families, and Foundations to address their unique challenges which allow his clients to view him, and his team, as responsible guardians of their wealth. His objectives are to simplify and coordinate his clients’ wealth management, to forge a close advisor/client relationship based on a full understanding of their needs, and deliver exceptional levels of multigenerational investment services.

ryansmith

Ryan Smith

Director – SignPost Cancer Dx Inc.

Ryan is President and CEO of Touchwood Properties Ltd and Smith Building & Development Ltd working primarily on the development\construction, management, and leasing of commercial property throughout southern Saskatchewan.  He has 30 years’ experience in the construction industry including retail building supply and residential\commercial general contacting.

Ryan is an invested partner in various business endeavors within the energy sector and has served in a board or leadership role of many local non-profits.

Peter Blaney 2019 head shot

Peter Blaney

Chief Executive Officer – SignPost Cancer Dx Inc.

Peter is the CEO Induran Ventures Inc. and founder of SignPost Cancer Dx Inc.

For 30 years Peter has been active in biotechnology startups that have led to products in biofuels, agricultural biotech, antiviral therapeutics, drug delivery, and molecular diagnostics.

As a General Partner Peter has managed limited partnerships, funds, and a portfolio of companies. His focus is on operations and works hands-on and directly with entrepreneurial teams to reach their goals.